Browsing: Prostate

December 16, 2022 Adapt or die. Adaptive planning has intriguing potential utility for radiation to the prostate, but what about…dun…

Top Line: The OncotypeDX Genomic Prostate Score (GPS) is a 17-gene assay that is prognostic of biochemical recurrence, distant metastasis,…

  Top Line: Does metastasis directed therapy alone delay the need for systemic therapy in patients with oligorecurrent prostate cancer?…

This huge analysis in trends of care detected an expected decrease in prostate cancer incidence following the notorious USPSTF recommendation…

Top Line: Does the sequence of short-course ADT and radiation matter when treating prostate cancer? The Study: In 2020, a…

Headline: Metastasis-directed radiation prolongs time off androgen deprivation therapy (ADT). The Study: We love this one, and your patients with…

Headline: Broadly speaking, patients with persistently elevated PSA after radical prostatectomy do not appear to benefit from the addition of…

Headline: Artificial intelligence using digital histopathology provides better prognostication than NCCN risk categories for men with localized prostate cancer. The…

Outcomes at 7 years from the PCS5 trial show noninferior overall survival, prostate cancer mortality, and biochemical recurrence when using…

October 24, 2022 Aim high. Headline: Low- versus high-dose rate brachytherapy boost during definitive prostate radiation results in slower recovery…